chr1-74041292-C-G

Variant summary

Our verdict is Likely benign. The variant received -2 ACMG points: 2P and 4B. PM2BP4_Strong

The NM_001105659.2(LRRIQ3):​c.1639G>C​(p.Glu547Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000124 in 1,612,602 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: 𝑓 0.0000066 ( 0 hom., cov: 32)
Exomes 𝑓: 6.8e-7 ( 0 hom. )

Consequence

LRRIQ3
NM_001105659.2 missense

Scores

19

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: -1.02

Publications

0 publications found
Variant links:
Genes affected
LRRIQ3 (HGNC:28318): (leucine rich repeats and IQ motif containing 3)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -2 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.042647928).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
LRRIQ3NM_001105659.2 linkc.1639G>C p.Glu547Gln missense_variant Exon 7 of 8 ENST00000354431.9 NP_001099129.1 A6PVS8-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
LRRIQ3ENST00000354431.9 linkc.1639G>C p.Glu547Gln missense_variant Exon 7 of 8 5 NM_001105659.2 ENSP00000346414.4 A6PVS8-1
LRRIQ3ENST00000395089.5 linkc.1639G>C p.Glu547Gln missense_variant Exon 6 of 7 5 ENSP00000378524.1 A6PVS8-1
LRRIQ3ENST00000417067.5 linkc.131-14323G>C intron_variant Intron 1 of 1 2 ENSP00000390376.1 A6PVT2
LRRIQ3ENST00000415760.5 linkn.*2703+399G>C intron_variant Intron 9 of 9 2 ENSP00000415319.1 A6PVS8-2

Frequencies

GnomAD3 genomes
AF:
0.00000658
AC:
1
AN:
151982
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0000656
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD4 exome
AF:
6.85e-7
AC:
1
AN:
1460620
Hom.:
0
Cov.:
32
AF XY:
0.00
AC XY:
0
AN XY:
726518
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
33434
American (AMR)
AF:
0.0000224
AC:
1
AN:
44602
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26088
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39644
South Asian (SAS)
AF:
0.00
AC:
0
AN:
85776
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53396
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5736
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
1111608
Other (OTH)
AF:
0.00
AC:
0
AN:
60336
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.525
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome
AF:
0.00000658
AC:
1
AN:
151982
Hom.:
0
Cov.:
32
AF XY:
0.0000135
AC XY:
1
AN XY:
74226
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
41396
American (AMR)
AF:
0.0000656
AC:
1
AN:
15238
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3468
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5184
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4822
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10572
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
316
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
67986
Other (OTH)
AF:
0.00
AC:
0
AN:
2088
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.525
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
0.00
Hom.:
0
Bravo
AF:
0.0000151

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Sep 27, 2022
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.1639G>C (p.E547Q) alteration is located in exon 7 (coding exon 6) of the LRRIQ3 gene. This alteration results from a G to C substitution at nucleotide position 1639, causing the glutamic acid (E) at amino acid position 547 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.12
BayesDel_addAF
Benign
-0.42
T
BayesDel_noAF
Benign
-0.84
CADD
Benign
0.17
DANN
Benign
0.75
DEOGEN2
Benign
0.0026
T;T
Eigen
Benign
-1.2
Eigen_PC
Benign
-1.3
FATHMM_MKL
Benign
0.037
N
LIST_S2
Benign
0.40
.;T
M_CAP
Benign
0.0042
T
MetaRNN
Benign
0.043
T;T
MetaSVM
Benign
-0.92
T
MutationAssessor
Benign
0.55
N;N
PhyloP100
-1.0
PrimateAI
Benign
0.33
T
PROVEAN
Benign
-0.19
N;N
REVEL
Benign
0.0020
Sift
Benign
0.22
T;T
Sift4G
Benign
0.32
T;T
Polyphen
0.033
B;B
Vest4
0.046
MutPred
0.22
Loss of ubiquitination at K546 (P = 0.0297);Loss of ubiquitination at K546 (P = 0.0297);
MVP
0.030
MPC
0.0043
ClinPred
0.047
T
GERP RS
-1.7
Varity_R
0.045
gMVP
0.012
Mutation Taster
=98/2
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1199989013; hg19: chr1-74506976; API